Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc is a leading company in providing scientific solutions with products and services in the fields of laboratory, research, and clinical diagnostics.
Price history of Thermo Fisher Scientific Inc
Price history of Thermo Fisher Scientific Inc
Performance & Momentum
Thermo Fisher Raises Dividend, Strengthens Data Partnerships
Thermo Fisher Scientific (Thermo Fisher Scientific Inc) announced a 10% increase in its quarterly dividend to $0.47 per share, reflecting confidence in its financial performance. Concurrently, the company formed a strategic partnership with Datavant to enhance the integration of real-world data in clinical research, bolstering its role in digital innovation within life sciences. Despite a slight decline in its stock price over the past year, Thermo Fisher outperforms peers in the medical devices sector, supported by a predominantly positive analyst consensus and strong anticipated growth in the preimplantation genetic testing market. These factors position the company favorably for medium-term growth.
Strategic Analysis
Thermo Fisher Scientific Inc • 2026
Thermo Fisher Scientific holds a key platform position in the scientific ecosystem, combining equipment, consumables, diagnostics, and services for laboratories and biotechnology. Its model is built on a diversified and largely recurring revenue base, and on its central role across the research, analysis, and quality control value chain. This specialization gives it strong structural resilience, with privileged exposure to long-term trends in healthcare and life sciences.
- Highly diversified portfolio covering instrumentation, consumables, diagnostics, and services, reducing dependence on any single end market
- Critical supplier position for laboratories and biopharmaceutical players, which creates high switching costs
- Defensive quality profile supported by recurring revenue from consumables and services
- Sensitivity to investment cycles in laboratories, biotech, and public or private research
- Valuation and expectations are often high, which can amplify corrections during periods of demand slowdown
Momentum appears moderately positive, but still not enough to speak of a fully confirmed turnaround. Recent trends suggest an improvement versus the weakness observed over several years, without entirely erasing the traces of a more uneven cycle. For investors, this reflects a high-quality name that is becoming more clearly visible again, but whose stock trajectory still depends on a sustained recovery in demand for equipment and research.
Similar stocks to Thermo Fisher Scientific Inc
Recent News
Thermo Fisher Scientific Inc
Thermo Fisher's AI Deal and Plant Closure Shape Strategy
4 months agoThermo Fisher Scientific (TMO) is strengthening its position through a partnership with NVIDIA to integrate AI into its laboratory workflows, creating growth opportunities in life sciences. Simultaneously, the company plans to close its Asheville plant within two years, resulting in 421 job cuts, which may negatively impact short-term performance. Despite concerns over debt and currency fluctuations, analysts remain optimistic, raising the price target to $700.
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
